NuVasive Q2 EPS $0.56, Inline, Sales $317.80M Miss $323.59M Estimate
Portfolio Pulse from Benzinga Newsdesk
NuVasive (NASDAQ:NUVA) reported Q2 earnings of $0.56 per share, in line with analyst consensus. This is a 19.15% increase from last year. However, the company's quarterly sales of $317.80 million missed the analyst consensus estimate of $323.59 million by 1.79%. Sales increased by 2.37% from the same period last year.
August 04, 2023 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
NuVasive's Q2 earnings met expectations, but sales missed estimates. This could potentially impact the company's stock price.
While NuVasive's earnings met expectations, the miss on sales could be a concern for investors. This mixed result could lead to uncertainty in the market, potentially impacting the stock's price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100